|
1
|
Brundel BJJM, Ai X, Hills MT, Kuipers MF,
Lip GYH and de Groot NMS: Atrial fibrillation. Nat Rev Dis Primers.
8(21)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Baman JR and Passman RS: Atrial
Fibrillation. JAMA. 325(2218)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tsigkas G, Apostolos A, Despotopoulos S,
Vasilagkos G, Kallergis E, Leventopoulos G, Mplani V and Davlouros
P: Heart failure and atrial fibrillation: New concepts in
pathophysiology, management, and future directions. Heart Fail Rev.
27:1201–1210. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Carlisle MA, Fudim M, DeVore AD and
Piccini JP: Heart failure and atrial fibrillation, like fire and
fury. JACC Heart Fail. 7:447–456. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bidaoui G, Assaf A and Marrouche N: Atrial
fibrillation in heart failure: Novel insights, challenges, and
treatment opportunities. Curr Heart Fail Rep. 22(3)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mundisugih J, Franke KB, Tully PJ, Munawar
DA, Kumar S and Mahajan R: Prevalence and prognostic implication of
atrial fibrillation in heart failure subtypes: Systematic review
and meta-analysis. Heart Lung Circ. 32:666–677. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kotecha D, Chudasama R, Lane DA, Kirchhof
P and Lip GY: Atrial fibrillation and heart failure due to reduced
versus preserved ejection fraction: A systematic review and
meta-analysis of death and adverse outcomes. Int J Cardiol.
203:660–666. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Becher N, Metzner A, Toennis T, Kirchhof P
and Schnabel RB: Atrial fibrillation burden: A new outcome
predictor and therapeutic target. Eur Heart J. 45:2824–2838.
2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Parkash R, Wells GA, Rouleau J, Talajic M,
Essebag V, Skanes A, Wilton SB, Verma A, Healey JS, Sterns L, et
al: Randomized ablation-based Rhythm-Control versus rate-control
trial in patients with heart failure and atrial fibrillation:
Results from the RAFT-AF trial. Circulation. 145:1693–1704.
2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Packer DL, Piccini JP, Monahan KH,
Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD,
Lee KL and Mark DB: CABANA Investigators. Ablation versus drug
therapy for atrial fibrillation in heart failure: Results From the
CABANA trial. Circulation. 143:1377–1390. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Parameswaran R, Al-Kaisey AM and Kalman
JM: Catheter ablation for atrial fibrillation: Current indications
and evolving technologies. Nat Rev Cardiol. 18:210–225.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rodriguez-Manero M, Schurmann P and
Valderrabano M: Ligament and vein of marshall: A therapeutic
opportunity in atrial fibrillation. Heart Rhythm. 13:593–601.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
O'Neill L, De Becker B, De Smet M,
Francois C, Tavernier R, Duytschaever M, Le Polain De Waroux JB and
Knecht S: Vein of marshall ethanol infusion for AF Ablation; A
review. J Clin Med. 13(2438)2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lador A and Valderrabano M: Atrial
fibrillation ablation using vein of marshall ethanol infusion.
Methodist Debakey Cardiovasc J. 17:52–55. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Valderrabano M, Peterson LE, Swarup V,
Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen
KA, Natale A, et al: Effect of catheter ablation with vein of
marshall ethanol infusion vs catheter ablation alone on persistent
atrial fibrillation: The VENUS randomized clinical trial. JAMA.
324:1620–1628. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Derval N, Duchateau J, Denis A, Ramirez
FD, Mahida S, André C, Krisai P, Nakatani Y, Kitamura T, Takigawa
M, et al: Marshall bundle elimination, Pulmonary vein isolation,
and line completion for ANatomical ablation of persistent atrial
fibrillation (Marshall-PLAN): Prospective, single-center study.
Heart Rhythm. 18:529–537. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lai Y, Liu X, Sang C, Long D, Li M, Ge W,
Liu X, Lu Z, Guo Q, Jiang C, et al: Effectiveness of ethanol
infusion into the vein of marshall combined with a fixed anatomical
ablation strategy (the ‘upgraded 2C3L’ approach) for catheter
ablation of persistent atrial fibrillation. J Cardiovasc
Electrophysiol. 32:1849–1856. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bruggmann C, Astaneh M, Lu H, Tozzi P,
Ltaief Z, Voirol P and Sadeghipour F: Management of atrial
fibrillation following cardiac surgery: Observational study and
development of a standardized protocol. Ann Pharmacother.
55:830–838. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tiver KD, Quah J, Lahiri A, Ganesan AN and
McGavigan AD: Atrial fibrillation burden: An update-the need for a
CHA2DS2-VASc-AFBurden score. Europace. 23:665–673. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhu W, He W, Guo L, Wang X and Hong K: The
HAS-BLED score for predicting major bleeding risk in anticoagulated
patients with atrial fibrillation: A systematic review and
meta-analysis. Clin Cardiol. 38:555–561. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Krisai P, Pambrun T, Nakatani Y, Nakashima
T, Takagi T, Kamakura T, Andre C, Cheniti G, Tixier R, Chauvel R,
et al: How to perform ethanol ablation of the vein of marshall for
treatment of atrial fibrillation. Heart Rhythm. 18:1083–1087.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wood KA and Barnes AH: Variations in
follow-up after atrial fibrillation ablation. J Am Assoc Nurse
Pract. 33:602–610. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wood KA, Barnes AH, Paul S, Hines KA and
Jackson KP: Symptom challenges after atrial fibrillation ablation.
Heart Lung. 46:425–431. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Valderrábano M, Liu X, Sasaridis C, Sidhu
J, Little S and Khoury DS: Ethanol infusion in the vein of
marshall: Adjunctive effects during ablation of atrial
fibrillation. Heart Rhythm. 6:1552–1558. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Takigawa M, Vlachos K, Martin CA, Bourier
F, Denis A, Kitamura T, Cheniti G, Lam A, Martin R, Frontera A, et
al: Acute and mid-term outcome of ethanol infusion of vein of
marshall for the treatment of perimitral flutter. Europace.
22:1252–1260. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kamakura T, Andre C, Duchateau J,
Nakashima T, Nakatani Y, Takagi T, Krisai P, Ascione C, Balbo C,
Tixier R, et al: Distribution of atrial low voltage induced by vein
of Marshall ethanol infusion. J Cardiovasc Electrophysiol.
33:1687–1693. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gao MY, Sang CH, Huang LH, Lai YW, Guo Q,
Liu XX, Zuo S, Li CY, Wang W, Guo XY, et al: Vein of marshall
ethanol infusion: First-step or adjunctive choice for perimitral
atrial tachycardia? Pacing Clin Electrophysiol. 46:20–30.
2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Benali K, Khairy P, Hammache N, Petzl A,
Da Costa A, Verma A, Andrade JG and Macle L: Procedure-related
complications of catheter ablation for atrial fibrillation. J Am
Coll Cardiol. 81:2089–2099. 2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xiao FY, Ju WZ, Chen HW, Huang WJ and Chen
M: A comparative study of pericardial effusion and pleural effusion
after cryoballoon ablation or radiofrequency catheter ablation of
atrial fibrillation. J Cardiovasc Electrophysiol. 31:1062–1067.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kamakura T, Derval N, Duchateau J,
Nakashima T, Cochet H, Sacher F, Hocini M, Jais P, Haïssaguerre M
and Pambrun T: Incidence of vein of marshall stenosis after ethanol
infusion: Is repeated ethanol infusion feasible? JACC Clin
Electrophysiol. 7:953–954. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu CM, Lo LW, Lin YJ, Lin CY, Chang SL,
Chung FP, Chao TF, Hu YF, Tuan TC, Liao JN, et al: Long-term
efficacy and safety of adjunctive ethanol infusion into the vein of
marshall during catheter ablation for nonparoxysmal atrial
fibrillation. J Cardiovasc Electrophysiol. 30:1215–1228.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gillis K, O'Neill L, Wielandts JY,
Hilfiker G, Almorad A, Lycke M, El Haddad M, le Polain Waroux de
JB, Tavernier R, Duytschaever M and Knecht S: Vein of marshall
ethanol infusion as first step for mitral isthmus linear ablation.
JACC Clin Electrophysiol. 8:367–376. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
He B, Zhao F, Yu W, Li Y, Wu X and Lu Z:
Ethanol infusion of vein of marshall for the treatment of
persistent atrial fibrillation: The basics and clinical practice. J
Cardiovasc Dev Dis. 9(270)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nattel S: Molecular and cellular
mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin
Electrophysiol. 3:425–435. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sohns C and Marrouche NF: Atrial
fibrillation and cardiac fibrosis. Eur Heart J. 41:1123–1131.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Reddy YNV, Borlaug BA and Gersh BJ:
Management of atrial fibrillation across the spectrum of heart
failure with preserved and reduced ejection fraction. Circulation.
146:339–357. 2022.PubMed/NCBI View Article : Google Scholar
|
